{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:06:36Z","timestamp":1779087996726,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"The Wellcome Trust","doi-asserted-by":"crossref","award":["096919\/Z\/11\/Z"],"award-info":[{"award-number":["096919\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2014,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mitochondrial diseases can arise from mutations either in mitochondrial DNA or in nuclear DNA encoding mitochondrially destined proteins. Currently, there is no cure for these diseases although treatments to ameliorate a subset of the symptoms are being developed. In this issue of\n                    <jats:italic>EMBO Molecular Medicine<\/jats:italic>\n                    , Khan\n                    <jats:italic>et\u00a0al<\/jats:italic>\n                    (2014) use a mouse model to test the efficacy of a simple dietary supplement of nicotinamide riboside to treat and prevent mitochondrial myopathies.\n                  <\/jats:p>","DOI":"10.15252\/emmm.201404179","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T00:55:52Z","timestamp":1400288152000},"page":"705-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Salvaging hope: Is increasing NAD+ a key to treating mitochondrial myopathy?"],"prefix":"10.1038","volume":"6","author":[{"given":"Robert N","family":"Lightowlers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia MA","family":"Chrzanowska\u2010Lightowlers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,16]]},"reference":[{"key":"BFEMMM201404179_CR1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","volume":"117","author":"P Bieganowski","year":"2004","unstructured":"Bieganowski P, Brenner C (2004) Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss\u2010Handler independent route to NAD+ in fungi and humans. Cell 117: 495\u2013502","journal-title":"Cell"},{"key":"BFEMMM201404179_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","volume":"28","author":"KL Bogan","year":"2008","unstructured":"Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28: 115\u2013130","journal-title":"Annu Rev Nutr"},{"key":"BFEMMM201404179_CR3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Canto","year":"2012","unstructured":"Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez\u2010Marcos PJ, Yamamoto H, Andreux PA, Cettour\u2010Rose P et\u00a0al (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high\u2010fat diet\u2010induced obesity. Cell Metab 15: 838\u2013847","journal-title":"Cell Metab"},{"key":"BFEMMM201404179_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cmet.2008.08.017","volume":"8","author":"JN Feige","year":"2008","unstructured":"Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, Lambert PD, Mataki C, Elliott PJ, Auwerx J (2008) Specific SIRT1 activation mimics low energy levels and protects against diet\u2010induced metabolic disorders by enhancing fat oxidation. Cell Metab 8: 347\u2013358","journal-title":"Cell Metab"},{"key":"BFEMMM201404179_CR5","doi-asserted-by":"crossref","first-page":"e76938","DOI":"10.1371\/journal.pone.0076938","volume":"8","author":"R Felici","year":"2013","unstructured":"Felici R, Lapucci A, Ramazzotti M, Chiarugi A (2013) Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria. PLoS ONE 8: e76938","journal-title":"PLoS ONE"},{"key":"BFEMMM201404179_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B et\u00a0al (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44: 177\u2013190","journal-title":"Mol Cell"},{"key":"BFEMMM201404179_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","volume":"6","author":"NA Khan","year":"2014","unstructured":"Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsstr\u00f6m S, Pasila L, Velagapudi Carroll CJ, Auwerx J, Suomalainen A (2014) Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin\u2010B3. EMBO Mol Med 6: 721\u2013731","journal-title":"EMBO Mol Med"},{"key":"BFEMMM201404179_CR8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart\u2010Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P et\u00a0al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC\u20101alpha. Cell 127: 1109\u20131122","journal-title":"Cell"},{"key":"BFEMMM201404179_CR9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbamcr.2012.02.019","volume":"1833","author":"MW Pellegrino","year":"2013","unstructured":"Pellegrino MW, Nargund AM, Haynes CM (2013) Signaling the mitochondrial unfolded protein response. Biochim Biophys Acta 1833: 410\u2013416","journal-title":"Biochim Biophys Acta"},{"key":"BFEMMM201404179_CR10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/jpet.107.120758","volume":"324","author":"AA Sauve","year":"2008","unstructured":"Sauve AA (2008) NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther 324: 883\u2013893","journal-title":"J Pharmacol Exp Ther"},{"key":"BFEMMM201404179_CR11","doi-asserted-by":"crossref","first-page":"17687","DOI":"10.1073\/pnas.0505551102","volume":"102","author":"H Tyynismaa","year":"2005","unstructured":"Tyynismaa H, Mjosund KP, Wanrooij S, Lappalainen I, Ylikallio E, Jalanko A, Spelbrink JN, Paetau A, Suomalainen A (2005) Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late\u2010onset mitochondrial disease in mice. Proc Natl Acad Sci USA 102: 17687\u201317692","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM201404179_CR12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","volume":"8","author":"T Wenz","year":"2008","unstructured":"Wenz T, Diaz F, Spiegelman BM, Moraes CT (2008) Activation of the PPAR\/PGC\u20101alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab 8: 249\u2013256","journal-title":"Cell Metab"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201404179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201404179","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201404179\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201404179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201404179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:10:55Z","timestamp":1779084655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201404179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,16]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"alternative-id":["BFEMMM201404179"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201404179","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,16]]},"assertion":[{"value":"16 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}